abs143.txt	thioridazine	is	an	antipsychotic	that	has	been	shown	to	induce	cell	death	andinhibit	self-renewal	in	a	broad	spectrum	of	cancer	cells		the	mechanisms	by	whichthese	effects	are	mediated	are	currently	unknown	but	are	presumed	to	result	fromthe	inhibition	of	dopamine	receptor	2	(drd2)		here	we	show	that	the	self-renewalof	several		but	not	all		triple-negative	breast	cancer	cell	lines	is	inhibited	bythioridazine		the	inhibition	of	self-renewal	by	thioridazine	in	these	cells	ismediated	by	drd2	inhibition		further		we	demonstrate	that	drd2	promotesself-renewal	in	these	cells	via	a	stat3-	and	il-6-dependent	mechanism		we	alsoshow	that	thioridazine	induces	a	g1	arrest	and	a	loss	in	cell	viability	in	alltested	cell	lines		however		the	reduction	in	proliferation	and	cell	viability	isindependent	of	drd2	and	stat3		our	results	indicate	that	although	there	are	celltypes	in	which	drd2	inhibition	results	in	inhibition	of	stat3	and	self-renewal	the	dramatic	block	in	cancer	cell	proliferation	across	many	cell	lines	caused	bythioridazine	treatment	is	independent	of	drd2	inhibition	
